Charles River Laboratories International, Inc. (CRL)

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.

Industry: Services-Commercial Physical & Biological Research (SIC 8731)

Market region: US

Address: 251 Ballardvale St, Wilmington, MA, 01887

Market capitalization

17.16 billion USD (17,157,827,986 USD)

Listing date

06/23/2000

Weighted shares outstanding

47,738,872

Share class shares outstanding

47,738,872

https://www.criver.com